Pharmacogenomic testing and outcome among depressed patients in a tertiary care outpatient psychiatric consultation practice
The authors tested the hypothesis that pharmacogenomic genotype knowledge is associated with better clinical and cost outcomes in depressed patients, after controlling for other factors that might differentiate tested and non-tested patients. Medical records of 251 patients, seen in the Mayo Clinic...
Main Authors: | Rundell, J R, Harmandayan, M, Staab, J P |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309479/ |
Similar Items
-
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
by: Winner, J, et al.
Published: (2013) -
Psychiatric pharmacogenomic testing in clinical practice
by: Mrazek, David A.
Published: (2010) -
Psychiatric outpatient consultation for seniors. Perspectives of family physicians, consultants, and patients / family: A descriptive study
by: Yaffe, Mark J, et al.
Published: (2005) -
Pharmacogenomics in depression and antidepressants
by: Bondy, Brigitta
Published: (2005) -
Unintentional Injuries among Psychiatric Outpatients with Major Depressive Disorder
by: Hung, Ching-I, et al.
Published: (2016)